ATP disodium nnu CAS 987-65-5

CAS:987-65-5

Ịdị ọcha:99%

Ụdị molekụla:C10H17N5NaO13P3

Ibu Molecular:531.18

EINECS:213-579-1

Oge Nchekwa:afọ 2

Ụdị okwu:ADENOSINETRIPHOSPHATEDISODIUM; ADENOSINETRIPHOSPHATE, DISODIUMSALT; ADENYLPYROPHOSPHORICACIDISODIUMSALT; ADENOSINE-5′-TRIPHOSPHATEHYDRATEDISODIUMSALT; ADENOSINE-5′-TRIPHOSPHATENA2-nnu; ADENOSINE-5′-TRIPHOSPHORICID,DISODIUM; ADENOSINE-5′-TRIPHOSPHORICACIDISODIUMDIHYDROGENSALT; ADENOSINE5′-TRIPHOSPHORICIDDISODIUMSALT

Hapụ Ozi Gị

Nkọwa ngwaahịa

Budata

Mkpado ngwaahịa

Gịnị bụ ATP disodium nnu CAS 987-65-5?

ATP disodium nnu bụ metabolite nke adenosine, multifunctional nucleoside triphosphate nke a na-eji dị ka coenzyme maka nnyefe ike intracellular n'ime sel. Ọ na-ebufe ike kemịkalụ n'ime sel maka metabolism. A na-eji nnu disodium ATP mee ka synthesize ribose-gbanwetụrụ deoxyadenosine diphosphate analogs dị ka P2Y1 ligands nnabata.

Nkọwapụta

Ọdịdị	White ntụ ntụ ma ọ bụ gbanyụọ- ọcha ntụ ntụ ma ọ bụ crystal ntụ ntụ, hygroscopic.
Nha urughuru	95% gafere 80 ntupu.
pH	2.5 ruo 3.5
Solubility	Soluble na mmiri; enweghị ike ime na ethanol & ether.
Oder	Oderless
Ọdịnaya mmiri	6.0% ~ 12.0%
Chloride	≤0.05%
Nnu ígwè	≤0.001%
Ọla dị arọ	≤0.001%
Ndu	≤2.0pm
Arsenic	≤1.0pm

Ngwa

1. Ụlọ ọrụ mmepụta ihe na nchọpụta sayensị na-eji
(1) Ngwa ngwa ịchọ mma: agbakwunyere na ngwaahịa nlekọta anụ ahụ na-egbochi ịka nká, ọ nwere ike melite ngbanwe akpụkpọ ahụ na glossiness site na ịgbalite ume cell metabolism.
(2) Ihe mgbakwunye nri: ejiri ya dị ka ihe nkwalite oriri na-edozi ahụ na ihe ọṅụṅụ egwuregwu na nri na-arụ ọrụ iji mejupụta ike ngwa ngwa.
2. Ebe ọgwụgwọ ụlọ ọgwụ
(1) Ọrịa sistem obi obi: ejiri ya maka nkụchi obi, myocarditis, infarction myocardial na cerebral arteriosclerosis, wdg, site na imeziwanye ike myocardial ume metabolism na ịgbasa akwara akwara (ịba ụba ọbara n'ihe dịka 30%), na-ebelata mgbaàmà myocardial ischemia. Dịka ọmụmaatụ, na ndị ọrịa nwere nnukwu myocardial infarction, ATP disodium nwere ike belata oge ọdịda nke ST ma belata uru kacha elu nke myocardial enzyme spectrum.
(2) Ọrịa usoro akwara: ọgwụgwọ inyeaka nke sequelae nke ọbara ọgbụgba ụbụrụ, mmebi ụbụrụ na atrophy muscular na-aga n'ihu, site na ịbanye n'ime ihe mgbochi ụbụrụ nke ọbara (permeability bụ ihe dị ka 65%), na-akwalite nrụzi mkpụrụ ndụ akwara na usoro mmeghari akwara, na imeziwanye ngwa ngwa akwara.
(3) Ọrịa metabolic: Na ọgwụgwọ ịba ọcha n'anya na cirrhosis, ATP disodium nwere ike ịkwalite ọrụ mitochondrial nke hepatocytes, mee ka mmezi hepatocyte dịkwuo ngwa, ma belata ọkwa ALT na AST; ọ nwekwara mmetụta nkwalite inyeaka na nsogbu ọrịa shuga (dịka neuropathy peripheral).
3. Mpaghara ngwa na-apụta
(1) Usoro nnyefe ọgwụ ezubere iche: Enwere ike iji ATP disodium dị ka onye na-ebufe ihe na-ebugharị, jikọtara ya na liposomes ma ọ bụ nanoparticles, iji nweta nnyefe ọgwụ ezubere iche site na endocytosis na-anabata ya. Dịka ọmụmaatụ, na ọgwụgwọ tumor, nanomedicine nke ATP gbanwere nwere ike imeziwanye arụmọrụ igbu egbu nke ọgwụ chemotherapy na mkpụrụ ndụ kansa.
(2) Omenala cell na biopharmaceuticals: Dị ka akụkụ bụ isi nke usoro omenala cell, ATP disodium nwere ike ịkwalite uto na okwu protein nke mkpụrụ ndụ CHO, mkpụrụ ndụ HEK293, wdg, ma na-ejikarị eme ihe na mmepụta ihe mgbochi monoclonal.